MONDELEZ INTERNATIONAL INC-A (MDLZ) Stock Fundamental Analysis

NASDAQ:MDLZ • US6092071058

59.43 USD
-3.16 (-5.05%)
Last: Feb 17, 2026, 02:58 PM
Fundamental Rating

4

Taking everything into account, MDLZ scores 4 out of 10 in our fundamental rating. MDLZ was compared to 87 industry peers in the Food Products industry. MDLZ has a medium profitability rating, but doesn't score so well on its financial health evaluation. MDLZ is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

  • MDLZ had positive earnings in the past year.
  • MDLZ had a positive operating cash flow in the past year.
  • Each year in the past 5 years MDLZ has been profitable.
  • MDLZ had a positive operating cash flow in each of the past 5 years.
MDLZ Yearly Net Income VS EBIT VS OCF VS FCFMDLZ Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B

1.2 Ratios

  • MDLZ has a Return On Assets of 3.43%. This is in the better half of the industry: MDLZ outperforms 66.67% of its industry peers.
  • MDLZ's Return On Equity of 9.49% is fine compared to the rest of the industry. MDLZ outperforms 75.86% of its industry peers.
  • The Return On Invested Capital of MDLZ (5.26%) is better than 63.22% of its industry peers.
  • MDLZ had an Average Return On Invested Capital over the past 3 years of 7.90%. This is significantly below the industry average of 28.07%.
Industry RankSector Rank
ROA 3.43%
ROE 9.49%
ROIC 5.26%
ROA(3y)5.7%
ROA(5y)5.47%
ROE(3y)14.7%
ROE(5y)13.89%
ROIC(3y)7.9%
ROIC(5y)7.13%
MDLZ Yearly ROA, ROE, ROICMDLZ Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15

1.3 Margins

  • The Profit Margin of MDLZ (6.36%) is better than 81.61% of its industry peers.
  • In the last couple of years the Profit Margin of MDLZ has declined.
  • MDLZ has a better Operating Margin (9.48%) than 74.71% of its industry peers.
  • In the last couple of years the Operating Margin of MDLZ has declined.
  • MDLZ's Gross Margin of 28.38% is fine compared to the rest of the industry. MDLZ outperforms 66.67% of its industry peers.
  • In the last couple of years the Gross Margin of MDLZ has declined.
Industry RankSector Rank
OM 9.48%
PM (TTM) 6.36%
GM 28.38%
OM growth 3Y-8%
OM growth 5Y-9.54%
PM growth 3Y-9.66%
PM growth 5Y-13.81%
GM growth 3Y-7.55%
GM growth 5Y-6.31%
MDLZ Yearly Profit, Operating, Gross MarginsMDLZ Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10 20 30

3

2. Health

2.1 Basic Checks

  • MDLZ has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
  • MDLZ has less shares outstanding than it did 1 year ago.
  • Compared to 5 years ago, MDLZ has less shares outstanding
  • MDLZ has a worse debt/assets ratio than last year.
MDLZ Yearly Shares OutstandingMDLZ Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B
MDLZ Yearly Total Debt VS Total AssetsMDLZ Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20B 40B 60B

2.2 Solvency

  • An Altman-Z score of 2.33 indicates that MDLZ is not a great score, but indicates only limited risk for bankruptcy at the moment.
  • MDLZ has a Altman-Z score (2.33) which is comparable to the rest of the industry.
  • MDLZ has a debt to FCF ratio of 6.55. This is a slightly negative value and a sign of low solvency as MDLZ would need 6.55 years to pay back of all of its debts.
  • MDLZ has a Debt to FCF ratio of 6.55. This is in the better half of the industry: MDLZ outperforms 68.97% of its industry peers.
  • A Debt/Equity ratio of 0.77 indicates that MDLZ is somewhat dependend on debt financing.
  • MDLZ has a worse Debt to Equity ratio (0.77) than 60.92% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.77
Debt/FCF 6.55
Altman-Z 2.33
ROIC/WACC0.71
WACC7.42%
MDLZ Yearly LT Debt VS Equity VS FCFMDLZ Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5B 10B 15B 20B 25B

2.3 Liquidity

  • A Current Ratio of 0.59 indicates that MDLZ may have some problems paying its short term obligations.
  • MDLZ has a worse Current ratio (0.59) than 86.21% of its industry peers.
  • MDLZ has a Quick Ratio of 0.59. This is a bad value and indicates that MDLZ is not financially healthy enough and could expect problems in meeting its short term obligations.
  • Looking at the Quick ratio, with a value of 0.39, MDLZ is doing worse than 80.46% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.59
Quick Ratio 0.39
MDLZ Yearly Current Assets VS Current LiabilitesMDLZ Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5B 10B 15B 20B

4

3. Growth

3.1 Past

  • The earnings per share for MDLZ have decreased strongly by -15.36% in the last year.
  • Measured over the past 5 years, MDLZ shows a small growth in Earnings Per Share. The EPS has been growing by 2.19% on average per year.
  • The Revenue has been growing slightly by 5.75% in the past year.
  • Measured over the past years, MDLZ shows a small growth in Revenue. The Revenue has been growing by 7.71% on average per year.
EPS 1Y (TTM)-15.36%
EPS 3Y-0.68%
EPS 5Y2.19%
EPS Q2Q%10.77%
Revenue 1Y (TTM)5.75%
Revenue growth 3Y6.96%
Revenue growth 5Y7.71%
Sales Q2Q%9.29%

3.2 Future

  • The Earnings Per Share is expected to grow by 8.76% on average over the next years. This is quite good.
  • The Revenue is expected to grow by 3.25% on average over the next years.
EPS Next Y9.49%
EPS Next 2Y9.35%
EPS Next 3Y9.06%
EPS Next 5Y8.76%
Revenue Next Year3.69%
Revenue Next 2Y3.62%
Revenue Next 3Y3.94%
Revenue Next 5Y3.25%

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
MDLZ Yearly Revenue VS EstimatesMDLZ Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 10B 20B 30B 40B 50B
MDLZ Yearly EPS VS EstimatesMDLZ Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 2 4 6

4

4. Valuation

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 20.35, MDLZ is valued on the expensive side.
  • MDLZ's Price/Earnings is on the same level as the industry average.
  • MDLZ's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 27.19.
  • Based on the Price/Forward Earnings ratio of 18.59, the valuation of MDLZ can be described as rather expensive.
  • Based on the Price/Forward Earnings ratio, MDLZ is valued a bit cheaper than 60.92% of the companies in the same industry.
  • MDLZ is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 28.06, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 20.35
Fwd PE 18.59
MDLZ Price Earnings VS Forward Price EarningsMDLZ Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of MDLZ is on the same level as its industry peers.
  • Based on the Price/Free Cash Flow ratio, MDLZ is valued a bit cheaper than 60.92% of the companies in the same industry.
Industry RankSector Rank
P/FCF 23.55
EV/EBITDA 19.27
MDLZ Per share dataMDLZ EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 -10 20 30

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
  • The decent profitability rating of MDLZ may justify a higher PE ratio.
PEG (NY)2.14
PEG (5Y)9.29
EPS Next 2Y9.35%
EPS Next 3Y9.06%

6

5. Dividend

5.1 Amount

  • With a Yearly Dividend Yield of 3.23%, MDLZ has a reasonable but not impressive dividend return.
  • MDLZ's Dividend Yield is a higher than the industry average which is at 2.27.
  • MDLZ's Dividend Yield is rather good when compared to the S&P500 average which is at 1.82.
Industry RankSector Rank
Dividend Yield 3.23%

5.2 History

  • The dividend of MDLZ is nicely growing with an annual growth rate of 10.23%!
  • MDLZ has been paying a dividend for at least 10 years, so it has a reliable track record.
  • MDLZ has not decreased their dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)10.23%
Div Incr Years11
Div Non Decr Years11
MDLZ Yearly Dividends per shareMDLZ Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.5 1 1.5

5.3 Sustainability

  • MDLZ pays out 101.47% of its income as dividend. This is not a sustainable payout ratio.
  • MDLZ's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP101.47%
EPS Next 2Y9.35%
EPS Next 3Y9.06%
MDLZ Yearly Income VS Free CF VS DividendMDLZ Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B 4B
MDLZ Dividend Payout.MDLZ Dividend Payout, showing the Payout Ratio.MDLZ Dividend Payout.PayoutRetained Earnings

MONDELEZ INTERNATIONAL INC-A

NASDAQ:MDLZ (2/17/2026, 2:58:09 PM)

59.43

-3.16 (-5.05%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryFood Products
Earnings (Last)02-03
Earnings (Next)04-27
Inst Owners89.35%
Inst Owner Change-1.49%
Ins Owners0.15%
Ins Owner Change5.05%
Market Cap76.18B
Revenue(TTM)38.54B
Net Income(TTM)2.45B
Analysts78.24
Price Target68.14 (14.66%)
Short Float %2.45%
Short Ratio2.61
Dividend
Industry RankSector Rank
Dividend Yield 3.23%
Yearly Dividend1.91
Dividend Growth(5Y)10.23%
DP101.47%
Div Incr Years11
Div Non Decr Years11
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)0.76%
Min EPS beat(2)0.24%
Max EPS beat(2)1.28%
EPS beat(4)4
Avg EPS beat(4)4.31%
Min EPS beat(4)0.24%
Max EPS beat(4)10.18%
EPS beat(8)7
Avg EPS beat(8)5.06%
EPS beat(12)11
Avg EPS beat(12)5.53%
EPS beat(16)15
Avg EPS beat(16)5.46%
Revenue beat(2)0
Avg Revenue beat(2)-0.89%
Min Revenue beat(2)-1.64%
Max Revenue beat(2)-0.15%
Revenue beat(4)0
Avg Revenue beat(4)-1.07%
Min Revenue beat(4)-2.09%
Max Revenue beat(4)-0.15%
Revenue beat(8)0
Avg Revenue beat(8)-1.43%
Revenue beat(12)3
Avg Revenue beat(12)-0.47%
Revenue beat(16)7
Avg Revenue beat(16)0.45%
PT rev (1m)-2.02%
PT rev (3m)-6.37%
EPS NQ rev (1m)-20.77%
EPS NQ rev (3m)-23.75%
EPS NY rev (1m)-0.24%
EPS NY rev (3m)-2.18%
Revenue NQ rev (1m)-1.45%
Revenue NQ rev (3m)-1.64%
Revenue NY rev (1m)-0.13%
Revenue NY rev (3m)-0.58%
Valuation
Industry RankSector Rank
PE 20.35
Fwd PE 18.59
P/S 1.98
P/FCF 23.55
P/OCF 16.88
P/B 2.95
P/tB N/A
EV/EBITDA 19.27
EPS(TTM)2.92
EY4.91%
EPS(NY)3.2
Fwd EY5.38%
FCF(TTM)2.52
FCFY4.25%
OCF(TTM)3.52
OCFY5.93%
SpS30.06
BVpS20.16
TBVpS-14.14
PEG (NY)2.14
PEG (5Y)9.29
Graham Number36.39
Profitability
Industry RankSector Rank
ROA 3.43%
ROE 9.49%
ROCE 7.37%
ROIC 5.26%
ROICexc 5.48%
ROICexgc 44.23%
OM 9.48%
PM (TTM) 6.36%
GM 28.38%
FCFM 8.39%
ROA(3y)5.7%
ROA(5y)5.47%
ROE(3y)14.7%
ROE(5y)13.89%
ROIC(3y)7.9%
ROIC(5y)7.13%
ROICexc(3y)8.16%
ROICexc(5y)7.43%
ROICexgc(3y)63.45%
ROICexgc(5y)50.76%
ROCE(3y)10.65%
ROCE(5y)9.63%
ROICexgc growth 3Y21.27%
ROICexgc growth 5Y4.15%
ROICexc growth 3Y1.33%
ROICexc growth 5Y-3.01%
OM growth 3Y-8%
OM growth 5Y-9.54%
PM growth 3Y-9.66%
PM growth 5Y-13.81%
GM growth 3Y-7.55%
GM growth 5Y-6.31%
F-Score5
Asset Turnover0.54
Health
Industry RankSector Rank
Debt/Equity 0.77
Debt/FCF 6.55
Debt/EBITDA 3.97
Cap/Depr 94.18%
Cap/Sales 3.32%
Interest Coverage 6.41
Cash Conversion 90.05%
Profit Quality 131.99%
Current Ratio 0.59
Quick Ratio 0.39
Altman-Z 2.33
F-Score5
WACC7.42%
ROIC/WACC0.71
Cap/Depr(3y)97.41%
Cap/Depr(5y)92.16%
Cap/Sales(3y)3.4%
Cap/Sales(5y)3.29%
Profit Quality(3y)93.68%
Profit Quality(5y)93.08%
High Growth Momentum
Growth
EPS 1Y (TTM)-15.36%
EPS 3Y-0.68%
EPS 5Y2.19%
EPS Q2Q%10.77%
EPS Next Y9.49%
EPS Next 2Y9.35%
EPS Next 3Y9.06%
EPS Next 5Y8.76%
Revenue 1Y (TTM)5.75%
Revenue growth 3Y6.96%
Revenue growth 5Y7.71%
Sales Q2Q%9.29%
Revenue Next Year3.69%
Revenue Next 2Y3.62%
Revenue Next 3Y3.94%
Revenue Next 5Y3.25%
EBIT growth 1Y-45.42%
EBIT growth 3Y-1.6%
EBIT growth 5Y-2.57%
EBIT Next Year37.45%
EBIT Next 3Y17.54%
EBIT Next 5Y13.29%
FCF growth 1Y-8.17%
FCF growth 3Y2.52%
FCF growth 5Y0.85%
OCF growth 1Y-8.07%
OCF growth 3Y4.92%
OCF growth 5Y2.63%

MONDELEZ INTERNATIONAL INC-A / MDLZ FAQ

Can you provide the ChartMill fundamental rating for MONDELEZ INTERNATIONAL INC-A?

ChartMill assigns a fundamental rating of 4 / 10 to MDLZ.


Can you provide the valuation status for MONDELEZ INTERNATIONAL INC-A?

ChartMill assigns a valuation rating of 4 / 10 to MONDELEZ INTERNATIONAL INC-A (MDLZ). This can be considered as Fairly Valued.


What is the profitability of MDLZ stock?

MONDELEZ INTERNATIONAL INC-A (MDLZ) has a profitability rating of 6 / 10.


Can you provide the PE and PB ratios for MDLZ stock?

The Price/Earnings (PE) ratio for MONDELEZ INTERNATIONAL INC-A (MDLZ) is 20.35 and the Price/Book (PB) ratio is 2.95.


Can you provide the dividend sustainability for MDLZ stock?

The dividend rating of MONDELEZ INTERNATIONAL INC-A (MDLZ) is 6 / 10 and the dividend payout ratio is 101.47%.